Replimune Group, Inc. Gains 101.33%

Wed, Jul 30, 2025 at 07:37 PM
Replimune Group, Inc. Gains 101.33%

Replimune Group, Inc. (REPL:NASDAQ) rocketted at $7.55, representing a gain of 101.3%. The stock appeared on our News Catalysts scanner on Wed, Jul 23, 2025 at 04:45 PM in the 'BIOTECH' category. From Wed, Jul 16, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days

The stock spiked on Mon, Jul 21, 2025 at $13.24 with a volume of 4M+.

About Replimune Group, Inc. (REPL:NASDAQ)

Replimune Group Inc is a clinical-stage biotechnology company. Its use proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The company's pipeline products include RP1, RP2, and RP3.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.